Please Wait.....
Report
Bone Cement for Spine Market By Type (Low Viscosity, Medium Viscosity, High Viscosity) , By Application (Vertebroplasty, Kyphoplasty) By End User (Hospitals, Specialty Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 280 Pages I Allied Market Research
Bone Cement for Spine Market
The bone cement for spine market was valued at $101.2 million in 2023 and is projected to reach $168.6 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.
The chemical used as a bone cement for spine is polymethyl methacrylate. The cement is specifically used for spinal surgeries such as kyphoplasty and vertebroplasty. This cement is administered to provide support to weakened broken bones, provide them with strength, and aid in relieving pain. A major attribute of the bone cement is its ability to solidify quickly, providing instant structural support and stability to the spine.
Increase in the prevalence of spinal surgeries across the globe is a key driver of the bone cement for spine market. In addition,the exponentially growing elderly population with high bone fragility is boosting the demand for bone cement for spine.In recent times, the trend of using bone cement as a material for the designing of scaffolds and bone implants through additive manufacturing is acquiring noteworthy traction. This enables the creation of tailored spine implants, according to the specific requirement of patients. Furthermore, the use of bone cement as a carrier for localized drug delivery is gaining significant traction in the healthcare industry.
However, bone cement for spine remains highly susceptible to fragmentation & foreign substance reaction inside the body, which leads to threatening conditions such as prosthetic loosening and periprosthetic osteolysis. These reactions hamper the development of the market. On the contrary, a constant surge in the number of spinal surgeries is projected to present lucrative opportunities for the market development. According to the statistics of the World Health Organization, approximately 15.4 million individuals weresuffering from spinal cord injuries in 2021 globally owing to several reasons such as road accidents, falls, or violence. Moreover, Statista-a global data and business intelligence platform-states that around 305,000 individuals in the U.S. had a spinal cord injury by the end of 2023. These eminent figures indicate a promising future for the bone cement for spine market.
Segment Review
The bone cement for spine market is segmented into type, application, end user, and region. On the basis of type, the market is divided into low viscosity, medium viscosity, and high viscosity. As per application, it is bifurcated into vertebroplasty and kyphoplasty. Depending on end user, it is classifiedinto hospitals and specialty surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the medium viscosity segment held a high share of the market in 2023.
As per application, the kyphoplasty segment acquired a high stake in the market in 2023.
Depending on end user, the hospitals segment was the highest shareholder of the market in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The key players operating in theglobal bone cement for spine market include Cardinal Health, Meta Biomed Co., Ltd, Heraeus Medical GmbH, Shanghai Rebone, Tecres S.P.A, OSARTIS GmbH, Stryker Corporation, Johnson & Johnson, Heraeus Medical, Smith & Nephew plc, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Type
- Low Viscosity
- Medium Viscosity
- High Viscosity
By Application
- Vertebroplasty
- Kyphoplasty
By End User
- Hospitals
- Specialty Surgical Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Cardinal Health
- Meta Biomed Co., Ltd
- Heraeus Medical GmbH
- Shanghai Rebone, Tecres S.P.A
- OSARTIS GmbH
- Stryker Corporation
- Johnson & Johnson
- Heraeus Medical
- Smith & Nephew plc
- Medtronic
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Component
4.2. Software
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Services
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Delivery Mode
5.2. On-Premises
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Cloud Based
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Drug Allergy Alerts
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Clinical Guidelines
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Drug-Drug Interactions
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Clinical Reminders
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Others
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
CHAPTER 7: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End User
7.2. Hospitals
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Clinics
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Ambulatory Care Centers
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
7.5. Academic And Research Institutes
7.5.1. Key Market Trends, Growth Factors and Opportunities
7.5.2. Market Size and Forecast, By Region
7.5.3. Market Share Analysis, By Country
CHAPTER 8: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By Component
8.2.3. Market Size and Forecast, By Delivery Mode
8.2.4. Market Size and Forecast, By Application
8.2.5. Market Size and Forecast, By End User
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Clinical Decision Support Platform Market
8.2.7.1. Market Size and Forecast, By Component
8.2.7.2. Market Size and Forecast, By Delivery Mode
8.2.7.3. Market Size and Forecast, By Application
8.2.7.4. Market Size and Forecast, By End User
8.2.8. Canada Clinical Decision Support Platform Market
8.2.8.1. Market Size and Forecast, By Component
8.2.8.2. Market Size and Forecast, By Delivery Mode
8.2.8.3. Market Size and Forecast, By Application
8.2.8.4. Market Size and Forecast, By End User
8.2.9. Mexico Clinical Decision Support Platform Market
8.2.9.1. Market Size and Forecast, By Component
8.2.9.2. Market Size and Forecast, By Delivery Mode
8.2.9.3. Market Size and Forecast, By Application
8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By Component
8.3.3. Market Size and Forecast, By Delivery Mode
8.3.4. Market Size and Forecast, By Application
8.3.5. Market Size and Forecast, By End User
8.3.6. Market Size and Forecast, By Country
8.3.7. France Clinical Decision Support Platform Market
8.3.7.1. Market Size and Forecast, By Component
8.3.7.2. Market Size and Forecast, By Delivery Mode
8.3.7.3. Market Size and Forecast, By Application
8.3.7.4. Market Size and Forecast, By End User
8.3.8. Germany Clinical Decision Support Platform Market
8.3.8.1. Market Size and Forecast, By Component
8.3.8.2. Market Size and Forecast, By Delivery Mode
8.3.8.3. Market Size and Forecast, By Application
8.3.8.4. Market Size and Forecast, By End User
8.3.9. Italy Clinical Decision Support Platform Market
8.3.9.1. Market Size and Forecast, By Component
8.3.9.2. Market Size and Forecast, By Delivery Mode
8.3.9.3. Market Size and Forecast, By Application
8.3.9.4. Market Size and Forecast, By End User
8.3.10. Spain Clinical Decision Support Platform Market
8.3.10.1. Market Size and Forecast, By Component
8.3.10.2. Market Size and Forecast, By Delivery Mode
8.3.10.3. Market Size and Forecast, By Application
8.3.10.4. Market Size and Forecast, By End User
8.3.11. UK Clinical Decision Support Platform Market
8.3.11.1. Market Size and Forecast, By Component
8.3.11.2. Market Size and Forecast, By Delivery Mode
8.3.11.3. Market Size and Forecast, By Application
8.3.11.4. Market Size and Forecast, By End User
8.3.12. Rest of Europe Clinical Decision Support Platform Market
8.3.12.1. Market Size and Forecast, By Component
8.3.12.2. Market Size and Forecast, By Delivery Mode
8.3.12.3. Market Size and Forecast, By Application
8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By Component
8.4.3. Market Size and Forecast, By Delivery Mode
8.4.4. Market Size and Forecast, By Application
8.4.5. Market Size and Forecast, By End User
8.4.6. Market Size and Forecast, By Country
8.4.7. China Clinical Decision Support Platform Market
8.4.7.1. Market Size and Forecast, By Component
8.4.7.2. Market Size and Forecast, By Delivery Mode
8.4.7.3. Market Size and Forecast, By Application
8.4.7.4. Market Size and Forecast, By End User
8.4.8. Japan Clinical Decision Support Platform Market
8.4.8.1. Market Size and Forecast, By Component
8.4.8.2. Market Size and Forecast, By Delivery Mode
8.4.8.3. Market Size and Forecast, By Application
8.4.8.4. Market Size and Forecast, By End User
8.4.9. India Clinical Decision Support Platform Market
8.4.9.1. Market Size and Forecast, By Component
8.4.9.2. Market Size and Forecast, By Delivery Mode
8.4.9.3. Market Size and Forecast, By Application
8.4.9.4. Market Size and Forecast, By End User
8.4.10. South Korea Clinical Decision Support Platform Market
8.4.10.1. Market Size and Forecast, By Component
8.4.10.2. Market Size and Forecast, By Delivery Mode
8.4.10.3. Market Size and Forecast, By Application
8.4.10.4. Market Size and Forecast, By End User
8.4.11. Australia Clinical Decision Support Platform Market
8.4.11.1. Market Size and Forecast, By Component
8.4.11.2. Market Size and Forecast, By Delivery Mode
8.4.11.3. Market Size and Forecast, By Application
8.4.11.4. Market Size and Forecast, By End User
8.4.12. Rest of Asia-Pacific Clinical Decision Support Platform Market
8.4.12.1. Market Size and Forecast, By Component
8.4.12.2. Market Size and Forecast, By Delivery Mode
8.4.12.3. Market Size and Forecast, By Application
8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By Component
8.5.3. Market Size and Forecast, By Delivery Mode
8.5.4. Market Size and Forecast, By Application
8.5.5. Market Size and Forecast, By End User
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Clinical Decision Support Platform Market
8.5.7.1. Market Size and Forecast, By Component
8.5.7.2. Market Size and Forecast, By Delivery Mode
8.5.7.3. Market Size and Forecast, By Application
8.5.7.4. Market Size and Forecast, By End User
8.5.8. South Africa Clinical Decision Support Platform Market
8.5.8.1. Market Size and Forecast, By Component
8.5.8.2. Market Size and Forecast, By Delivery Mode
8.5.8.3. Market Size and Forecast, By Application
8.5.8.4. Market Size and Forecast, By End User
8.5.9. Saudi Arabia Clinical Decision Support Platform Market
8.5.9.1. Market Size and Forecast, By Component
8.5.9.2. Market Size and Forecast, By Delivery Mode
8.5.9.3. Market Size and Forecast, By Application
8.5.9.4. Market Size and Forecast, By End User
8.5.10. Rest of LAMEA Clinical Decision Support Platform Market
8.5.10.1. Market Size and Forecast, By Component
8.5.10.2. Market Size and Forecast, By Delivery Mode
8.5.10.3. Market Size and Forecast, By Application
8.5.10.4. Market Size and Forecast, By End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. Cerner Corporation
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Company Snapshot
10.1.4. Operating Business Segments
10.1.5. Product Portfolio
10.1.6. Business Performance
10.1.7. Key Strategic Moves and Developments
10.2. EPIC Systems Corporation
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Company Snapshot
10.2.4. Operating Business Segments
10.2.5. Product Portfolio
10.2.6. Business Performance
10.2.7. Key Strategic Moves and Developments
10.3. IBM
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Company Snapshot
10.3.4. Operating Business Segments
10.3.5. Product Portfolio
10.3.6. Business Performance
10.3.7. Key Strategic Moves and Developments
10.4. Change Healthcare Corporation
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Company Snapshot
10.4.4. Operating Business Segments
10.4.5. Product Portfolio
10.4.6. Business Performance
10.4.7. Key Strategic Moves and Developments
10.5. Medical Information Technology Inc
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Company Snapshot
10.5.4. Operating Business Segments
10.5.5. Product Portfolio
10.5.6. Business Performance
10.5.7. Key Strategic Moves and Developments
10.6. Koninklijke Philips NV
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Company Snapshot
10.6.4. Operating Business Segments
10.6.5. Product Portfolio
10.6.6. Business Performance
10.6.7. Key Strategic Moves and Developments
10.7. Siemens Healthcare
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Company Snapshot
10.7.4. Operating Business Segments
10.7.5. Product Portfolio
10.7.6. Business Performance
10.7.7. Key Strategic Moves and Developments
10.8. Allscripts Healthcare Solutions Inc.
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Company Snapshot
10.8.4. Operating Business Segments
10.8.5. Product Portfolio
10.8.6. Business Performance
10.8.7. Key Strategic Moves and Developments
10.9. Wolters Kluwer NV
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Company Snapshot
10.9.4. Operating Business Segments
10.9.5. Product Portfolio
10.9.6. Business Performance
10.9.7. Key Strategic Moves and Developments
10.10. McKesson Corporation.
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Company Snapshot
10.10.4. Operating Business Segments
10.10.5. Product Portfolio
10.10.6. Business Performance
10.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 2. BONE CEMENT FOR SPINE MARKET FOR LOW VISCOSITY, BY REGION, 2024 - 2033 ($MILLION)
TABLE 3. BONE CEMENT FOR SPINE MARKET FOR MEDIUM VISCOSITY, BY REGION, 2024 - 2033 ($MILLION)
TABLE 4. BONE CEMENT FOR SPINE MARKET FOR HIGH VISCOSITY, BY REGION, 2024 - 2033 ($MILLION)
TABLE 5. GLOBAL BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 6. BONE CEMENT FOR SPINE MARKET FOR VERTEBROPLASTY, BY REGION, 2024 - 2033 ($MILLION)
TABLE 7. BONE CEMENT FOR SPINE MARKET FOR KYPHOPLASTY, BY REGION, 2024 - 2033 ($MILLION)
TABLE 8. GLOBAL BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 9. BONE CEMENT FOR SPINE MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 10. BONE CEMENT FOR SPINE MARKET FOR SPECIALTY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 11. BONE CEMENT FOR SPINE MARKET, BY REGION, 2024 - 2033 ($MILLION)
TABLE 12. NORTH AMERICA BONE CEMENT FOR SPINE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 13. NORTH AMERICA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 14. NORTH AMERICA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 15. NORTH AMERICA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 16. U.S. BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 17. U.S. BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 18. U.S. BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 19. CANADA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 20. CANADA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 21. CANADA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 22. MEXICO BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 23. MEXICO BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 24. MEXICO BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 25. EUROPE BONE CEMENT FOR SPINE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 26. EUROPE BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 27. EUROPE BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 28. EUROPE BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 29. GERMANY BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 30. GERMANY BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 31. GERMANY BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 32. FRANCE BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 33. FRANCE BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 34. FRANCE BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 35. UK BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 36. UK BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 37. UK BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 38. ITALY BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 39. ITALY BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 40. ITALY BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 41. SPAIN BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 42. SPAIN BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 43. SPAIN BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 44. REST OF EUROPE BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 45. REST OF EUROPE BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 46. REST OF EUROPE BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 47. ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 48. ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 49. ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 50. ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 51. JAPAN BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 52. JAPAN BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 53. JAPAN BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 54. CHINA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 55. CHINA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 56. CHINA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 57. AUSTRALIA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 58. AUSTRALIA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 59. AUSTRALIA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 60. INDIA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 61. INDIA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 62. INDIA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 63. SOUTH KOREA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 64. SOUTH KOREA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 65. SOUTH KOREA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 69. LAMEA BONE CEMENT FOR SPINE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 70. LAMEA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 71. LAMEA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 72. LAMEA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 73. BRAZIL BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 74. BRAZIL BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 75. BRAZIL BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 76. SAUDI ARABIA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 77. SAUDI ARABIA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 78. SAUDI ARABIA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 79. SOUTH AFRICA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 80. SOUTH AFRICA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 81. SOUTH AFRICA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 82. REST OF LAMEA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 83. REST OF LAMEA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 84. REST OF LAMEA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 85. CARDINAL HEALTH: KEY EXECUTIVES
TABLE 86. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 87. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 88. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 89. CARDINAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90. META BIOMED CO., LTD: KEY EXECUTIVES
TABLE 91. META BIOMED CO., LTD: COMPANY SNAPSHOT
TABLE 92. META BIOMED CO., LTD: OPERATING SEGMENTS
TABLE 93. META BIOMED CO., LTD: PRODUCT PORTFOLIO
TABLE 94. META BIOMED CO., LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. HERAEUS MEDICAL GMBH: KEY EXECUTIVES
TABLE 96. HERAEUS MEDICAL GMBH: COMPANY SNAPSHOT
TABLE 97. HERAEUS MEDICAL GMBH: OPERATING SEGMENTS
TABLE 98. HERAEUS MEDICAL GMBH: PRODUCT PORTFOLIO
TABLE 99. HERAEUS MEDICAL GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. SHANGHAI REBONE, TECRES S.P.A: KEY EXECUTIVES
TABLE 101. SHANGHAI REBONE, TECRES S.P.A: COMPANY SNAPSHOT
TABLE 102. SHANGHAI REBONE, TECRES S.P.A: OPERATING SEGMENTS
TABLE 103. SHANGHAI REBONE, TECRES S.P.A: PRODUCT PORTFOLIO
TABLE 104. SHANGHAI REBONE, TECRES S.P.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. OSARTIS GMBH: KEY EXECUTIVES
TABLE 106. OSARTIS GMBH: COMPANY SNAPSHOT
TABLE 107. OSARTIS GMBH: OPERATING SEGMENTS
TABLE 108. OSARTIS GMBH: PRODUCT PORTFOLIO
TABLE 109. OSARTIS GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 111. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 112. STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 113. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 114. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 116. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 117. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 118. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 119. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120. HERAEUS MEDICAL: KEY EXECUTIVES
TABLE 121. HERAEUS MEDICAL: COMPANY SNAPSHOT
TABLE 122. HERAEUS MEDICAL: OPERATING SEGMENTS
TABLE 123. HERAEUS MEDICAL: PRODUCT PORTFOLIO
TABLE 124. HERAEUS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 125. SMITH AND NEPHEW PLC: KEY EXECUTIVES
TABLE 126. SMITH AND NEPHEW PLC: COMPANY SNAPSHOT
TABLE 127. SMITH AND NEPHEW PLC: OPERATING SEGMENTS
TABLE 128. SMITH AND NEPHEW PLC: PRODUCT PORTFOLIO
TABLE 129. SMITH AND NEPHEW PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130. MEDTRONIC: KEY EXECUTIVES
TABLE 131. MEDTRONIC: COMPANY SNAPSHOT
TABLE 132. MEDTRONIC: OPERATING SEGMENTS
TABLE 133. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 134. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL BONE CEMENT FOR SPINE MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF BONE CEMENT FOR SPINE MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN BONE CEMENT FOR SPINE MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBONE CEMENT FOR SPINE MARKET
FIGURE 10. GLOBAL BONE CEMENT FOR SPINE MARKET SEGMENTATION, BY TYPE
FIGURE 11. BONE CEMENT FOR SPINE MARKET FOR LOW VISCOSITY, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 12. BONE CEMENT FOR SPINE MARKET FOR MEDIUM VISCOSITY, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 13. BONE CEMENT FOR SPINE MARKET FOR HIGH VISCOSITY, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 14. GLOBAL BONE CEMENT FOR SPINE MARKET SEGMENTATION, BY APPLICATION
FIGURE 15. BONE CEMENT FOR SPINE MARKET FOR VERTEBROPLASTY, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 16. BONE CEMENT FOR SPINE MARKET FOR KYPHOPLASTY, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 17. GLOBAL BONE CEMENT FOR SPINE MARKET SEGMENTATION, BY END USER
FIGURE 18. BONE CEMENT FOR SPINE MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 19. BONE CEMENT FOR SPINE MARKET FOR SPECIALTY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 24. COMPETITIVE DASHBOARD
FIGURE 25. COMPETITIVE HEATMAP: BONE CEMENT FOR SPINE MARKET
FIGURE 26. TOP PLAYER POSITIONING, 2023
FIGURE 27. CARDINAL HEALTH: NET SALES, 2021-2023 ($MILLION)
FIGURE 28. CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. META BIOMED CO., LTD: NET SALES, 2021-2023 ($MILLION)
FIGURE 31. META BIOMED CO., LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. META BIOMED CO., LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. HERAEUS MEDICAL GMBH: NET SALES, 2021-2023 ($MILLION)
FIGURE 34. HERAEUS MEDICAL GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. HERAEUS MEDICAL GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. SHANGHAI REBONE, TECRES S.P.A: NET SALES, 2021-2023 ($MILLION)
FIGURE 37. SHANGHAI REBONE, TECRES S.P.A: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. SHANGHAI REBONE, TECRES S.P.A: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. OSARTIS GMBH: NET SALES, 2021-2023 ($MILLION)
FIGURE 40. OSARTIS GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. OSARTIS GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. STRYKER CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 43. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($MILLION)
FIGURE 46. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. HERAEUS MEDICAL: NET SALES, 2021-2023 ($MILLION)
FIGURE 49. HERAEUS MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. HERAEUS MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. SMITH AND NEPHEW PLC: NET SALES, 2021-2023 ($MILLION)
FIGURE 52. SMITH AND NEPHEW PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. SMITH AND NEPHEW PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. MEDTRONIC: NET SALES, 2021-2023 ($MILLION)
FIGURE 55. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security